4.58
+0.14(+3.15%)
Currency In USD
Address
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Belgium
Phone
32 1 022 23 55
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
183
First IPO Date
April 28, 2021
| Name | Title | Pay | Year Born |
| Mr. Olivier Taelman | Chief Executive Officer & Executive Director | 902,842 | 1972 |
| Mr. Robert Taub MBA | Co-Founder & Chairman | 136,447 | 1947 |
| Mr. Loic Moreau | President of International | 524,287 | 1981 |
| Mikaela Kirkwood | Corporate Communication & Investor Relations Manager | 0 | N/A |
| Ms. An Moonen | General Counsel | 0 | N/A |
| Mr. Bruno Onkelinx | Chief Technical Officer | 0 | 1972 |
| Mr. Remi Renard | Chief of Staff | 0 | N/A |
| Mr. Jeyakumar Subbaroyan | Chief Clinical Officer | 0 | N/A |
| Ms. Maggie McGowan | Chief HR Officer | 0 | N/A |
| Mr. John Landry | Chief Financial Officer | 0 | 1973 |
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.